|
| |
Inotek Pharmaceuticals CorporationInotek Pharmaceuticals Corporation is a private, high-growth, development-stage pharmaceutical firm founded in 1996. The Company has a deep and diverse pipeline with seven products in pre-clinical or clinical development targeting oncology, cardiovascular and inflammatory diseases. The Company is pursuing indications in hospital cardiovascular markets as well as specialty care markets including dermatology, gastroenterology and oncology. All of the Company's technologies were discovered and developed by Inotek researchers. The Company currently has more than 120 employees, based in its headquarters and main laboratories in Beverly, Massachusetts and its clinical operations and GMP manufacturing facilities in Israel
| Contact Details: |
| 100 Cummings Center4th Floor |
| Beverly |
| Massachusetts |
| 01915 |
| United States of America |
| Tel: | 978-232-9660 |
| Fax: | 978-232-8975 |
| Email: | info@inotekcorp.com |
| WWW: | www.inotekcorp.com/

|
|
Loading...
|
Recent Publications by Inotek Pharmaceuticals Corporation: |  |
Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c]isoquinolin- 5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one.
[reaction: see text] The synthesis of... | 10th February, 2006
| Inotek Pharmaceuticals Corporation, 100 Cummings Center, Beverly,
| Org Lett. 2005 Apr 28;7(9):1753-6.
DOI Direct Link |
Mechanisms of cell necrosis.
OBJECTIVE: Rotigotine (Neupro) is formulated as a transdermal delivery... | 19th January, 2006
| Inotek Pharmaceuticals Corporation, Beverly, MA, USA.
| Crit Care Med. 2005 Dec;33(12 Suppl):S530-4.
|
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.
Activation of poly(ADP-ribose) polymerase (PARP) is an important factor in... | 13th January, 2006
| Inotek Pharmaceuticals Corporation, Beverly, Massachusetts, USA.
| J Pharmacol Exp Ther. 2005 Nov;315(2):812-20. Epub 2005 Aug 3.
DOI Direct Link |
Cytokines stimulate expression of inducible nitric oxide synthase in DLD-1 human adenocarcinoma cells by activating poly(A) polymerase.
OBJECTIVE: The stimulation of epithelial cells by cytokines or... | 3rd November, 2005
| Inotek Pharmaceuticals Corporation, 100 Cummings Center, Suite 419E,
| Inflamm Res. 2004 Nov;53(11):604-8.
|
Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.
Angiotensin II (AII) contributes to the pathogenesis of many... | 20th October, 2005
| Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center,
| Mol Med. 2004 Jan-Jun;10(1-6):28-35.
|
→View more Inotek Pharmaceuticals Corporation research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 460 times since April 2007, the link to the organisation's website has been followed 81 times Recent Search Terms used to find this page: inotek israel | inotek israel | inotek pharmaceutical beverly ma | inoteck pharma | Captain Mardens Seafoods Inc | Inotek Pharmaceuticals cumming center | Inotek Corp israel | Inotek Pharmaceuticals | . Search for more companies in Beverly Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Inotek Pharmaceuticals Corporation |